BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 19644322)

  • 1. Multimodal therapy for vertebral involvement of systemic mastocytosis.
    Krüger A; Hamann C; Brendel C; Ramaswamy A; Schnabel M; Neubauer A; Hofbauer LC
    Spine (Phila Pa 1976); 2009 Aug; 34(17):E626-8. PubMed ID: 19644322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone involvement and osteoporosis in mastocytosis.
    Rossini M; Zanotti R; Viapiana O; Tripi G; Orsolini G; Idolazzi L; Bonadonna P; Schena D; Escribano L; Adami S; Gatti D
    Immunol Allergy Clin North Am; 2014 May; 34(2):383-96. PubMed ID: 24745681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Severe therapy refractive osteoporosis : A rare differential diagnosis].
    Gehlen M; Lazarescu AD; Hinz C; Schmidt N; Pfeifer M; Werner M; Weidemann HF; Schwarz-Eywill M; Maier A
    Z Rheumatol; 2016 Sep; 75(7):729-35. PubMed ID: 27193336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic mastocytosis--rare cause of pathologic vertebral fracture].
    Stamm AC; Burbelko M; Rominger M
    Rofo; 2008 Jan; 180(1):57-9. PubMed ID: 17968773
    [No Abstract]   [Full Text] [Related]  

  • 5. Biopsy of osteoporotic vertebral compression fractures during kyphoplasty: unsuspected histologic findings of chronic osteitis without clinical evidence of osteomyelitis.
    Allen RT; Kum JB; Weidner N; Hulst JB; Garfin SR
    Spine (Phila Pa 1976); 2009 Jun; 34(14):1486-91. PubMed ID: 19483668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mastocytosis presenting as osteoporosis--a case report.
    Mathew R; Dhillon V; Shepherd P
    Clin Rheumatol; 2009 Jul; 28(7):865-6. PubMed ID: 19305945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic mastocytosis: bone impact].
    Spivacow FR; Sarli M; Nakutny R
    Medicina (B Aires); 2012; 72(3):201-6. PubMed ID: 22763156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of mediator release in systemic mastocytosis is associated with reversal of bone changes.
    Graves L; Stechschulte DJ; Morris DC; Lukert BP
    J Bone Miner Res; 1990 Nov; 5(11):1113-9. PubMed ID: 2270775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Osteoporotic vertebral fractures in systemic mastocytosis without skin involvement].
    Pankow W; Ehlenz K; Buhr T; Pflüger KH; von Wichert P
    Dtsch Med Wochenschr; 1992 Nov; 117(45):1717-22. PubMed ID: 1330476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid in osteoporosis secondary to mastocytosis.
    Rossini M; Zanotti R; Viapiana O; Tripi G; Idolazzi L; Biondan M; Orsolini G; Bonadonna P; Adami S; Gatti D
    Am J Med; 2014 Nov; 127(11):1127.e1-1127.e4. PubMed ID: 24954632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive systemic mastocytosis presenting with hepatic cholestasis.
    Kupfer SS; Hart J; Mohanty SR
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):901-5. PubMed ID: 17873616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic mastocytosis and bone involvement in a cohort of 75 patients.
    Barete S; Assous N; de Gennes C; Grandpeix C; Feger F; Palmerini F; Dubreuil P; Arock M; Roux C; Launay JM; Fraitag S; Canioni D; Billemont B; Suarez F; Lanternier F; Lortholary O; Hermine O; Francès C
    Ann Rheum Dis; 2010 Oct; 69(10):1838-41. PubMed ID: 20570833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vertebral fractures and increased sensitivity to corticosteroids in a child with ulcerative colitis: successful use of pamidronate.
    Lucarelli S; Borrelli O; Paganelli M; Capocaccia P; Frediani T; Ferri F; Cucchiara S
    J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):533-5. PubMed ID: 17033531
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: pathologic long bone fracture in a patient with systemic mastocytosis.
    King JJ; Crawford EA; Iwenofu OH; Fox EJ
    Clin Orthop Relat Res; 2007 Jun; 459():263-9. PubMed ID: 17327804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis with vertebral fractures in young males, due to bone marrow mastocytosis: a report of two cases.
    Manara M; Varenna M; Cantoni S; Parafioriti A; Gallazzi MB; Sinigaglia L
    Clin Exp Rheumatol; 2010; 28(1):97-100. PubMed ID: 20346248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of the jaw bones in systemic mastocytosis.
    Castling B; Smith AT; Myers B
    Br J Oral Maxillofac Surg; 2006 Apr; 44(2):87-8. PubMed ID: 15896888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New development in bisphosphonate treatment. Bisphosphonates for the treatment of glucocorticoid-induced osteoporosis].
    Soen S
    Clin Calcium; 2009 Jan; 19(1):44-53. PubMed ID: 19122264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Back pain treatment in post-menopausal osteoporosis with vertebral fractures.
    Ulivieri FM
    Aging Clin Exp Res; 2007 Jun; 19(3 Suppl):21-3. PubMed ID: 18180603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staged-injection procedure to prevent cement leakage during vertebroplasty: an in vitro study.
    Wu ZX; Wei L; Hu YY; Wang HQ; Wan SY; Wang J; Han Y
    Spine (Phila Pa 1976); 2007 Oct; 32(22):2437-42. PubMed ID: 18090082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.